Monday, February 25, 2008

Fw: Current concepts in malignant pleural mesothelioma.



----- Forwarded Message ----
From: HubMed - mesothelioma <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Wednesday, February 20, 2008 3:40:52 AM
Subject: Current concepts in malignant pleural mesothelioma.

[1]Expert Rev Anticancer Ther. 2008 Feb; 8(2): 293-303
Kaufman AJ, Pass HI

Malignant pleural mesothelioma (MPM) is a rare but lethal cancer associated with asbestos exposure. Worldwide, the incidence of MPM is expected to increase over the next 20 years. The molecular and genetic profiling of MPM tumors and patients, and improved understanding of the pathogenesis of MPM may lead to novel diagnostic, preventative and therapeutic strategies. Treatment options for MPM remain limited and no consensus exists at this time. Multimodality therapy that combines surgery, chemotherapy and radiation offers the best chance for long-term survival in select patients.



___
Source: http://www.hubmed.org/display.cgi?uids=18279069
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 


Be a better friend, newshound, and know-it-all with Yahoo! Mobile. Try it now.

Fw: Pericardial malignant mesothelioma: a latent complication of radiotherapy?



----- Forwarded Message ----
From: HubMed - mesothelioma <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Wednesday, February 20, 2008 3:40:51 AM
Subject: Pericardial malignant mesothelioma: a latent complication of radiotherapy?

[1]Eur J Cardiothorac Surg. 2008 Feb 13;
Small GR, Nicolson M, Buchan K, Broadhurst P

Pericardial diseases can be difficult to differentiate from myocardial conditions. Diagnosis can be challenging and often requires the use of different imaging modalities. Here, we describe a case which presented with common cardiac symptoms which were shown to be the result of a rare condition. A 62-year-old lady presented with left femoral artery embolism. Post-embolectomy she developed cardiac failure. Three months previously an acellular, sterile pericardial effusion had been drained. In 1993 a left mastectomy and axillary node clearance was performed for breast cancer. Adjuvant chemotherapy and radiotherapy were administered. Examination revealed a raised jugular venous pressure (JVP) with rapid Y descent and Kussmaul's sign. CT chest and abdomen found no recurrence of breast carcinoma. Cardiac MRI demonstrated thickened pericardium. At cardiac catheterisation haemodynamic responses consistent with constrictive pericarditis were seen. Pericardectomy was performed. Histology revealed pericardial epithelioid malignant mesothelioma. 18-FDG-PET CT post-operatively was negative in the pericardium and pleura. Chemotherapy with pemetrexed and carboplatin was given. The patient died 9 months after presentation. Radiotherapy and asbestos exposure are both associated with pericardial mesothelioma and the aetiology in this case was not clear. The condition carries a poor prognosis and is invariable fatal although newer chemotherapeutic regimens have prolonged survival times.



___
Source: http://www.hubmed.org/display.cgi?uids=18280176
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 


Never miss a thing. Make Yahoo your homepage.

Fw: [Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital]



----- Forwarded Message ----
From: HubMed - mesothelioma <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Wednesday, February 20, 2008 3:40:52 AM
Subject: [Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital]

[1]J Bras Pneumol. 2008 Jan; 34(1): 13-20
Terra RM, Teixeira LR, Beyruti R, Takagaki TY, Vargas FS, Jatene FB

OBJECTIVE: To evaluate the experience in diagnosing and treating malignant pleural mesothelioma (MPM) accumulated over 5 years in a tertiary public hospital. METHODS: The medical charts of the patients diagnosed with MPM between January of 2000 and February of 2005 were evaluated retrospectively. RESULTS: Of the 17 patients analyzed, 14 were male and 3 were female. The mean age was 54.1 years (range, 13-75 years). The biopsy specimens for histopathological examination were obtained through thoracoscopy in 9 patients (53%), Cope needle in 5 (29.5%), and open pleural biopsy in 3 (17.5%). The following histological types were identified: epithelial, in 14 patients (82%); sarcomatoid, in 1 (6%); and biphasic, in 2 (12%). The therapeutic approaches used were as follows: multimodal (pleuropneumonectomy and adjuvant radiotherapy and chemotherapy) in 6 patients (35%); chemotherapy and radiotherapy in 6 (35%); radiotherapy alone in 3 (17.5%); and chemotherapy alone in 2 (12%). The mean survival was 11 months (range, 1-26 months). CONCLUSIONS: In the cases studied, an integrated multidisciplinary approach was used, and a highly complex hospital infrastructure was available for the diagnosis and treatment of MPM, as recommended in the literature. However, the mean survival was only 11 months, reflecting the aggressiveness of the disease.



___
Source: http://www.hubmed.org/display.cgi?uids=18278371
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 


Never miss a thing. Make Yahoo your homepage.

Fw: [Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital]



----- Forwarded Message ----
From: HubMed - mesothelioma diagnosis <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Wednesday, February 20, 2008 3:40:21 AM
Subject: [Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital]

[1]J Bras Pneumol. 2008 Jan; 34(1): 13-20
Terra RM, Teixeira LR, Beyruti R, Takagaki TY, Vargas FS, Jatene FB

OBJECTIVE: To evaluate the experience in diagnosing and treating malignant pleural mesothelioma (MPM) accumulated over 5 years in a tertiary public hospital. METHODS: The medical charts of the patients diagnosed with MPM between January of 2000 and February of 2005 were evaluated retrospectively. RESULTS: Of the 17 patients analyzed, 14 were male and 3 were female. The mean age was 54.1 years (range, 13-75 years). The biopsy specimens for histopathological examination were obtained through thoracoscopy in 9 patients (53%), Cope needle in 5 (29.5%), and open pleural biopsy in 3 (17.5%). The following histological types were identified: epithelial, in 14 patients (82%); sarcomatoid, in 1 (6%); and biphasic, in 2 (12%). The therapeutic approaches used were as follows: multimodal (pleuropneumonectomy and adjuvant radiotherapy and chemotherapy) in 6 patients (35%); chemotherapy and radiotherapy in 6 (35%); radiotherapy alone in 3 (17.5%); and chemotherapy alone in 2 (12%). The mean survival was 11 months (range, 1-26 months). CONCLUSIONS: In the cases studied, an integrated multidisciplinary approach was used, and a highly complex hospital infrastructure was available for the diagnosis and treatment of MPM, as recommended in the literature. However, the mean survival was only 11 months, reflecting the aggressiveness of the disease.



___
Source: http://www.hubmed.org/display.cgi?uids=18278371
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 


Be a better friend, newshound, and know-it-all with Yahoo! Mobile. Try it now.

Fw: Pericardial malignant mesothelioma: a latent complication of radiotherapy?



----- Forwarded Message ----
From: HubMed - mesothelioma diagnosis <rssfwd@rssfwd.com>
To: shell8377@yahoo.com
Sent: Wednesday, February 20, 2008 3:40:21 AM
Subject: Pericardial malignant mesothelioma: a latent complication of radiotherapy?

[1]Eur J Cardiothorac Surg. 2008 Feb 13;
Small GR, Nicolson M, Buchan K, Broadhurst P

Pericardial diseases can be difficult to differentiate from myocardial conditions. Diagnosis can be challenging and often requires the use of different imaging modalities. Here, we describe a case which presented with common cardiac symptoms which were shown to be the result of a rare condition. A 62-year-old lady presented with left femoral artery embolism. Post-embolectomy she developed cardiac failure. Three months previously an acellular, sterile pericardial effusion had been drained. In 1993 a left mastectomy and axillary node clearance was performed for breast cancer. Adjuvant chemotherapy and radiotherapy were administered. Examination revealed a raised jugular venous pressure (JVP) with rapid Y descent and Kussmaul's sign. CT chest and abdomen found no recurrence of breast carcinoma. Cardiac MRI demonstrated thickened pericardium. At cardiac catheterisation haemodynamic responses consistent with constrictive pericarditis were seen. Pericardectomy was performed. Histology revealed pericardial epithelioid malignant mesothelioma. 18-FDG-PET CT post-operatively was negative in the pericardium and pleura. Chemotherapy with pemetrexed and carboplatin was given. The patient died 9 months after presentation. Radiotherapy and asbestos exposure are both associated with pericardial mesothelioma and the aetiology in this case was not clear. The condition carries a poor prognosis and is invariable fatal although newer chemotherapeutic regimens have prolonged survival times.



___
Source: http://www.hubmed.org/display.cgi?uids=18280176
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 


Never miss a thing. Make Yahoo your homepage.

Fwd: Veterans Organizations Call for Lung Cancer Screening



---------- Forwarded message ----------
From: Live Search News: asbestos cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Veterans Organizations Call for Lung Cancer Screening
To: mesothelioma77@gmail.com


PR Newswire - ... those whose active duty service exposed them to Agent Orange, asbestos, spent nuclear fuels, propellant gases and other carcinogens," Coady said. Admiral Coady, a thirty-four year Navy veteran who never smoked, was diagnosed with lung cancer three ...

Thu, 14 Feb 2008 21:53:00 GMT

___
Source: http://sev.prnewswire.com/health-care-hospitals/20080214/DC1429914022008-1.html
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc